Loading clinical trials...
Loading clinical trials...
This clinical trial will test the efficacy and safety of oral colchicine in prevention of proliferative vitreoretinopathy (PVR) in cases of rhegmatogenous retinal detachment
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shahid Beheshti University of Medical Sciences
NCT05331664 · Rhegmatogenous Retinal Detachment
NCT06997874 · Rhegmatogenous Retinal Detachment
NCT06694259 · Rhegmatogenous Retinal Detachment
NCT06541574 · Proliferative Vitreoretinopathy, Rhegmatogenous Retinal Detachment
NCT06347302 · Rhegmatogenous Retinal Detachments
Hamid Ahmadieh,MD
Tehran, Tehran Province
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions